The persistence of deficits in cognitive performance in major depressive patients taking maintenance antidepressant medication was assessed by examining groups of patients in clinical remission, stable on one of a range of tricyclics or selective serotonin re-uptake inhibitors (SSRIs) for at least 3 months, compared with controls. Measures of critical flicker fusion (CFF), choice reaction time (CRT), subjective sedation, and anticholinergic side-effect score were made. Tricyclic antidepressants (TCAs) produce a significant deficit in critical flicker fusion threshold compared both to controls and SSRIs. Similar effects were seen with choice reaction times which were significantly affected by age. Sedation scores were significantly higher with TCAs than SSRIs. Anticholinergic side effects were strongly related to CFF, less so to visual analogue sedating scales and not significantly to CRT. The effect measured by CFF is different from sedation, and may be related to the anticholinergic potency of the drug; it may be considered a drug-induced pseudodementia. This effect represents a risk factor for accidents during maintenance therapy and may impair work and leisure performance. The relative risk of weight gain with TCAs compared to SSRIs in women was 5.92 (95% CI 1.79-19.50).
Ali M.R., Amir T. ( 1991) Critical flicker frequency under monocular and binocular conditions. Percept Motor Skills72: 383-386
2.
Amado-Boccara I., Gougoulis N., Poirer-Littre M.F., Galinowski A., Loo H. ( 1994) Incidence des antidepresseurs sur les fonctions cognitives. Revue de la littérature. Encéphale20: 65-77
3.
American Psychiatric Association (1987) Diagnostic and statistical manual of the American Psychiatric Association, Version III, Revised. APA, Washington, DC
4.
Atwal A., Chordia A., Wanchoo A., Jain J. ( 1988) Cognitive test performance correlates of CFF. Ind J Curr Psychol Res3: 62-63
5.
Bartfai A., Wiesel F.A. (1986) Effect of sulpiride on vigilance in healthy subjects . Int J Psychophysiol4: 1-5
6.
Bayer A.J., Pathy M.S., Ankier S.I. (1983) Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol.16: 371-376
7.
Bhattacharya S.K., Tripathi S.R. (1989) The effects of times of day on cognitive and visuo-motor performance efficiency. J Hum Ergol18: 23-31
8.
Blom M.W., Sommers D.K., Bartel P.R., Van der Meyden C.H. (1991) A comparison of psychomotor and EEG effects of desipramine, clomipramine and fluoxetine. Med Sci Res19: 751-752
9.
Borland R.G., Brennan D.H., Nicholson A.N., Smith P.A. (1985) Studies on the possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine). Hum Toxicol4: 293-300
10.
Bruce M., Scott N., Shine P., Lader M. (1992) Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatr49: 867-869
11.
Clark W.C., Rutschman J., Link R., Brown J.C. (1963) Comparison of flicker-fusion thresholds obtained by the methods of forced-choice and limits on psychiatric patients. Percept Motor Skills16: 19-30
12.
Crome P., Newman B. (1978) A comparison of the effects of single doses of mianserin and amitriptyline on psychomotor tests in normal volunteers. J Int Med Res6: 430-434
13.
Curran H.V., Lader M. (1986) The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects. Eur J Clin Pharmacol29: 601-607
14.
Decker M.W., McGaugh J.L. (1991) The role of interaction between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse7: 151-168
15.
Doogan D.P., Caillard V. (1992) Sertraline in the prevention of depression. Br J Psychiatr160: 217-222
16.
Dye L., Hindmarch I. (1991) The effects of clobazam on critical flicker fusion threshold and symptomatology during the menstrual cycle. Hum Psychopharmacol6: 129-137
17.
Ellinwood E.H., Linnoila M., Easter M., Molter D.W. (1981) Onset of peak impairment after diazepam and alcohol . Clin Pharmacol Ther30: 534-538
18.
Eric L. ( 1991) A prospective double blind comparative multicentre study of paroxetine and placebo in preventing recurrent major depressive episodes . Biol Psychiatr29(Suppl): 2545
19.
Fairweather D.B., Kerr J.S., Harrison D.A., Moon C.A., Hindmarch I. (1993) A double blind comparison of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol8: 41-47
20.
Flood J.F., Cherkin A. (1987) Fluoxetine enhances memory processing in mice. Psychopharmacology93: 36-43
21.
Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarrett D.B., Mallinger A.G., Thase M.E., McEachran A.B., Grochocinski V.J. (1990) Three year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatr47: 1093-1099
22.
Frank E., Kupfer D.J., Wagner E.F., McEachran A.B., Comes C. (1991) Efficacy of interpersonal psychotherapy as a maintenance treatment for recurrent depression. Arch Gen Psychiatr48: 1053-1059
23.
Freemantle N., House A., Song F., Mason J.M., Sheldon T.A. (1994) Prescribing selective serotonin reuptake inhibitors as a strategy for prevention of suicide. Br Med J309: 249-253
24.
Greden J.F. (1993) Antidepressant medication: when to discontinue and how to stop. J Clin Psychiatr54(Suppl): 39-47
25.
Gross P.F., Tiffin A. (1991) The economic costs of depression in Australia and the potential economic effects of a new antidepressant (fluoxetine). Health Economics monograph No. 39. Institute of Health Economics and Technology Assessment. Sydney, Australia
26.
Grundstrom R., Holmberg G., Ledermann H., Livstedt B. (1977) Sedative properties of doxepin in comparison with diazepam. Psychopharmacology54: 165-169
27.
Grundstrom R., Holmberg G., Hansen T. (1978) Degree of sedation obtained with various doses of diazepam and nitrazepam. Acta Pharmacol Toxicol43: 13-18
28.
Hale A.S. (1994) A medical model for community care? J Mental Health3: 147-148
29.
Hamilton M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr23: 56-62
30.
Hanks G.W. (1984) The effects of amitriptyline and nomifensine on critical flicker fusion threshold in an elderly patient population. In Nomifensine, Royal Society of Medicine International Congress and Symposium series, Vol. 70, Royal Society of Medicine, London, pp. 95-98
31.
Hindmarch I. (1975) A 1,4 benzodiazepine temazepam: effect on some physiological parameters. Arzneim-Forsch25: 1836-1839
32.
Hindmarch I. (1988) Lofepramine and psychomotor function. Int Clin Psychopharmacol3(Suppl 2): 71-77
33.
Hindmarch I. (1990) Immediate and overnight effects of zopiclone 7.5 mg and nitrazepam 5 mg with ethanol, on psychomotor performance and memory in healthy volunteers. Int J Psychopharmacol5(Suppl 2): 105-113
34.
Hindmarch I. (1991) Accident proneness and illness proneness. J R Soc Med84: 570
35.
Hindmarch I. (1994) Relevant psychometric tests for antidepressants and anxiolytics. Int Clin Psychopharmacol9(Suppl 1): 27-33
36.
Hindmarch I., Bhatti J.Z. (1988) Psychopharmacological effects of sertraline in normal, healthy volunteers. Eur J Clin Pharmacol35: 221-223
37.
Hindmarch I., Harrison C. (1988) The effects of paroxetine and other antidepressants with alcohol on psychomotor activity related to car driving. Hum Psychopharmacol3: 13-20
38.
Hindmarch I., Barwell F., Alford C. (1990) Behavioural toxicity of antidepressants. In Leonard B, Spencer P (eds), Antidepressants: 30 years on. CNS Publishers , London, pp. 404-409.
39.
Hindmarch I., Shillingford J., Shillingford C. (1990) The effects of sertraline on psychomotor performance in elderly volunteers. J Clin Psychiatr51 (12: Suppl B): 34-36
40.
Hindmarch U., Kerr J.S., Sherwood N. (1991) The effects of alcohol and other drugs on psychomotor performance and cognitive function. Alcohol and Alcoholism26: 71-79
41.
Jansen J M H, Andrews J.S. (1994) The effects of serotonergic drugs on short-term spacial memory in rats. J Psychopharmacol8: 157-63
42.
Jensen A.R. (1983) Critical flicker frequency and intelligence. Intelligence7: 217-225
43.
Jones D N C, Higgins G.A. (1994) Scopolamine and selective attention. J Psychopharmacol8(Suppl): Abstr. 54
44.
Joyce P., Paykel E.S. (1989) Predictors of drug response in depression. Arch Gen Psychiatr46: 89-99
45.
Kerr J.S., Hindmarch I. (1991) Effects of ketanserin on psychomotor performance, mood and sleep. Med Sci Res19: 493-494
46.
Kerr J.S., Hindmarch I., Sherwood N. (1991) Correlation between doses of oxazepam and their effects on performance of a standardised test battery. Eur J Clin Pharmacol42: 507-510
47.
Kerr J.S., Sherwood N., Hindmarch I. (1991) The comparative psychopharmacology of 5HT reuptake inhibitors. Hum Psychopharmacol6: 313-317
48.
Kerr J.S., Fairweather D.B., Mahendran R., Hindmarch I. (1992) The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly . Int Clin Psychopharmacol7: 101-108
49.
Khateb A., Fort P., Alonso A., Jones B.E., Mühlethaler M. (1993) Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basilis neurons. Eur J Neurosci5: 541-547
50.
King D.J., Henry G. (1992) The effect of neuroleptics on cognitive and psychomotor function: a preliminary study in healthy volunteers. Br J Psychiatr160: 647-653
51.
Kupfer D.J., Frank E.F., Perel J.M., Cornes C., Mallinger A.G., Thase M.E., McEachran A.B., Grochocinski V.J. (1992) Five year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatr49: 769-773
52.
Lachenmayr B.J., Kojetinsky S., Ostermaier N., Angstwurm K., Vivell P.M., Schaumberger M. (1994) The different effects of aging on normal sensitivity in flicker and light-sense perimetry. Invest Ophthalmol Visual Sci35: 2741-2748
53.
Lee E.H., Lin W.R., Chen H.Y., Shiu W.H., Liang K.C. (1992) Fluoxetine and 8-OH-DPAT in lateral septum enhances and impairs retention of an inhibitory avoidance response in rats. Physiol Behav51: 681-688
54.
Lucki I., Rickels K., Geller AM (1986) Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology88: 426-433
55.
McDonald J.B. (1985) The role of drugs in falls in the elderly. Clin Geriatr Med1: 621-636
56.
MacNab M.W., Foltz E.L., Sweitzer J. (1985) Evaluation of signal detection theory on the effects of psychotropic drugs on critical flicker-fusion frequency in normal subjects . Psychopharmacology85: 431-435
57.
MacPhee G J A, Goldie C., Roulston D., Potter L., Agnew E., Laidlaw J., Brodie M.J. (1986) Effect of carbamazepine on psychomotor performance in naive subjects. Eur J Clin Pharmacol30: 37-42
58.
Miles P.W. (1950) Flicker fusion fields. I. The effect of age and pupil size. Am J Ophthalmol33: 769-772
Moon C.A., Davey A. (1988) The efficacy and residual effects of trazodone (150 mg nocte) and mianserin in the treatment of depressed general practice patients. Psychopharmacology95(Suppl): 7-13
61.
Muller-Oerlinghausen B., Hammann S., Herrmann W.M., Kropf D. (1979) Effects of lithium on vigilance, psychomotoric performance and mood. Pharmakopsychiatr Neuro-Psychopharmakol12: 388-396
62.
Norris H. (1971) The actions of sedatives on brainstem occulomotor systems in man. Neuropharmacology10: 181-191
63.
Norusis M.J. (1993) SPSS/PC advanced statistics V4.0, SPSS Inc, Chicago
64.
Ogura C., Kishimoto A., Mizukawa R., Hazama H., Honma H., Kawahara K. (1983) Age differences in effects on blood pressure, flicker fusion frequency, salivation and pharmacokinetics of single oral doses of dothiepin and amitriptyline. Eur J Clin Pharmacol25: 811-814
65.
Ogura C., Kishimoto A., Mizukawa R., Matsubayashi M., Omura F., Kunimoto N. (1987) Comparative study of the effects of 9 antidepressants on several physiological parameters in healthy volunteers. Neuropsychobiology17: 139-144
66.
Palva E.S. (1985) Gender-related differences in diazepam effects on performance. Med Biol63: 92-95
67.
Quitkin F.M. (1985) The importance of dosage in prescribing antidepressants . Br J Psychiatr147: 593-597
68.
Ramaekers J.G., Swijgman H.F., O'Hanlon J.F. (1992) Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo . Psychopharmacology106(Suppl): 62-67
69.
Rammsayer T., Netter P. (1988) Effects of changes in brain 5-HT activity on indicators of cortical arousal. Int Clin Psychopharmacol3: 231-237
70.
Ray W.A., Griffin M.R., Schaffner W., Baugh D.K., Melton L.J. (1987) Psychotropic drug use and the risk of hip fracture . New Engl J Med316: 363-339
71.
Reynolds C.F., Frank E., Perel J.M., Imber S., Kupfer D.J. (1994) Maintenance therapies in late-life depression. Neuropsychopharmacology10: 61S
72.
Robertson M.M., Abou-Saleh M.T., Harrison D.A., Nairac B.L., Edwards D R I, Lock T., Burns R.A., Katona C L E (1994) A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness. J Psychopharmacol8: 98-103
73.
Sakulsripong M., Curran H.V., Lader M. (1991) Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo . Eur J Clin Pharmacol40: 43-48
74.
Saletu B., Grunberger J., Rajna P. (1983) Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine. Br J Clin Pharmacol15(Suppl 3): 369-383
75.
Scott J., Eccleston D., Boys R. ( 1992) Can we predict the persistence of depression. Br J Psychiatr161: 633-637
76.
Sherwood N., Kerr J.S., Hindmarch I. (1992) Psychomotor performance in smokers following single and repeated doses of nicotine gum. Psychopharmacology108: 432-436
77.
Smith J.M., Misiak H. (1979) Critical Flicker Frequency (CFF) and psychotropic drugs in normal human subjects—a review. Psychopharmacology47: 175-182
78.
Song F., Freemantle N., Sheldon T.A., House A., Watson P., Long A., Mason J. (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br Med J306: 683-687
79.
Warot D., Molinier P., Lacomblez L., Payan C. (1989) Dose related effects of trimipramine on psychomotor function, memory, and autonomic nervous system activity in healthy volunteers . Hum Psychopharmacol4: 121-127
80.
Warrington S.J. (1991) Clinical implications of the pharmacology of sertraline . Int Clin Psychopharmacol6(Suppl 2): 11-21
81.
Warrington S.J., Dana-Haeri J., Sinclair A.J. (1989) Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men. Acta Neurol Scand80(350, Suppl): 42-44
82.
Wesnes K.A., Simpson P.M. (1994) An increased profile of cognitive impairment with acute doses of haloperidol 23 days apart. J Psychopharmacol8(Suppl): Abstr. 79
83.
Wesnes K., Simpson P., Kidd A. ( 1988) An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s.c. Hum Psychopharmacol3: 27-41
